Don't Take a Position in Morgan Stanley Stocks Without Knowing Its Fundamentals!

By Susan Ramirez • Tuesday, September 12 10:10 • Permanent Link

Morgan Stanley logged a -0.1% change during today's morning session, and is now trading at a price of $83.45 per share. The S&P 500 index moved -0.0%. MS's trading volume is 594,955 compared to the stock's average volume of 6,942,641.

Morgan Stanley trades -14.53% away from its average analyst target price of $97.64 per share. The 23 analysts following the stock have set target prices ranging from $80.0 to $112.0, and on average have given Morgan Stanley a rating of buy.

If you are considering an investment in MS, you'll want to know the following:

Morgan Stanley's current price is -20.3% below its Graham number of $104.71, which implies the stock has a margin of safety
Morgan Stanley has moved -2.0% over the last year, and the S&P 500 logged a change of 15.0%
Based on its trailing earnings per share of 5.69, Morgan Stanley has a trailing 12 month Price to Earnings (P/E) ratio of 14.7 while the S&P 500 average is 15.97
MS has a forward P/E ratio of 11.3 based on its forward 12 month price to earnings (EPS) of $7.38 per share
The company has a price to earnings growth (PEG) ratio of 2.89 — a number near or below 1 signifying that Morgan Stanley is fairly valued compared to its estimated growth potential
Its Price to Book (P/B) ratio is 1.51 compared to its sector average of 1.57
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia.
Based in New York, the company has 82,000 full time employees and a market cap of $138.27 Billion. Morgan Stanley currently returns an annual dividend yield of 3.8%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.